Infectious Diseases Grants

Burroughs Wellcome Fund/ASTMH Postdoctoral Fellowship in Tropical Infectious Diseases
Application Deadline: Oct. 15, 2008

American Society of Tropical Medicine and Hygiene
111 Deer Lake Road, Suite 100
Deerfield, Illinois 60015 USA

By Phone or Fax:
847-480-9592
Fax: 847-480-9282

Willis A.Reid Jr -Student Research Fund

Call for 2009 Willis A. Reid Jr. Reseach Proposals

In 2004, the American Society of Parasitologists began a new program to provide small grants to students studying parasitology. At this time, the ASP is able to fund one graduate student ($1000) and one undergraduate student ($500) doing research in the field of parasitology.

Proposals must be sent to the ASP Education Committee (electronically) and received by January 16, 2009 for review.
Eligibility:

The competition is open to all undergraduate and graduate level ASP student members affiliated with institutions or major professors who have limited or no grant money to support student research. Both the student and his/her major professor must be members of the ASP at the time of application. (Applications for membership may be found at http://asp.unl.edu/).

Documentation: 1)A brief proposal written by the student (maximum of 3 pages, double-spaced, 11 pt typeface minimum in either MS Word, WordPerfect, or PDF format only) outlining the student's proposed research must be submitted, along with a separate, detailed 1-page budget of how the money will be spent. Money can only be used for supplies, equipment, and travel expenses for research (not to attend and present results at meetings). 2) The student also must include a brief CV (1-2 pages). 3) A letter of support will be required from the student's major professor stating why the student needs funding, as well as justifying the student's academic and research accomplishments.

Proposals must be sent to the ASP Education Committee (electronically) and received by January 16, 2009 for review. Awardees will be notified by April 1, 2009 and awards dispersed on that date.

NOTE: At the end of one year (April 1, 2010), awardees must submit a brief report (1-2 pages) summarizing their research activities over the year, outlining what was accomplished and the expenses incurred related to the initial proposal.

Send proposals to: Lee Couch mailto:lcouch@unm.edu

Immunization Incentive Grants

Application Deadline: December 15, 2008

The APhA and APhA Foundation will award up to four $1,000 grants. The grants provide seed money to help pharmacists implement or support an immunization activity (new or expansion) targeted to identified populations / vaccines. Preference will be given to proposals targeted to the adolescent or adult populations, those that involve new vaccines, or proposals that address documentation of immunizations.

The Incentive Grants program is intended to focus pharmacists’ attention on the need to reengineer their practices along lines that incorporate more specific patient-centered services and enhance health care delivery with the use of today’s technology. The project should concentrate on an innovative patient care service that is of significance to the identified pharmacy care settings and that can be evaluated for its relevance.

This program is made possible as part of a Cooperative Agreement between the Centers for Disease Control and Prevention and the American Pharmacists Association entitled "Pharmacists: Connecting, Communicating and Collaborating for Improved Community Health" (Cooperative Agreement No. 1U66 IP000114).

While the APhA and APhA Foundation’s headquarter building undergoes a massive renovation and expansion, the current address for the APhA Foundation is:

1100 15th Street, NW, Suite 400
Washington, DC 20005-1707
Telephone: (202) 429-7565
Email: info@aphafoundation.org

Federal Pharmacists Incentive Grants

Application Deadline: December 15, 2008

The APhA Foundation will award grants in the amount of $2,000 for projects to be initiated for military or civil service pharmacists working in the Army, Air Force, Coast Guard, Navy, Department of Veterans Affairs or the Public Health Service. The grants provide seed money to help pharmacists in federal sector practice settings with start-up costs to establish a new pharmaceutical care project or to use as continuing development costs to expand an already existing project, and to encourage them to share their experiences with other pharmacists within the federal sector.

The Federal Pharmacists Incentive Grants program is intended to focus pharmacists’ attention on the need to re-engineer their practices along lines that incorporate more specific patient-centered services and enhance health care delivery with the use of today’s technology. The project should concentrate on a new, innovative patient care service or expand an already existing service that is of significance to the pharmacy profession and that can be evaluated for its relevance.

The incentive grant project proposals must be in one of the following areas:

* Osteoporosis
* Oncology
* Hepatitis-C
* HIV/AIDS
* Other Infectious Diseases
* Medication Therapy Management Services

The APhA Foundation has awarded incentive grants to pharmacists in a variety of practice settings for over ten years. This is the second year for the Federal Pharmacists Incentive Grants program which is made possible with support from The Roche Foundation.

While the APhA and APhA Foundation’s headquarter building undergoes a massive renovation and expansion, the current address for the APhA Foundation is:

1100 15th Street, NW, Suite 400
Washington, DC 20005-1707
Telephone: (202) 429-7565
Email: info@aphafoundation.org

The John M. Lloyd Foundation honors John's contribution to our world by awarding more than $400,000 in small grants each year to organizations around the world, supporting organizations and projects that demonstrate critical and creative thinking about the root causes of HIV/AIDS, and that seek solutions that are compassionate and courageous.

In 2006 the John M. Lloyd Foundation celebrated its 15th anniversary and the Board took the opportunity to both reflect on the Foundation's history and to strategize how the Foundation's future grants might have greater impact. This process has led to a restructuring of the Foundation's programs with the goal to provide deeper and more targeted support to those individuals, projects, and organizations that are leading the fight to end the pandemic and whose work matches one or more of the Foundation's four funding objectives.

The Foundation gives preference to organizations and projects that advocate for evidence-based policies, those that mobilize awareness and support for AIDS programs, and those that employ innovation to battle the HIV/AIDS pandemic. The Foundation's specific funding objectives are:

1. To increase funding from public and private sectors to address the HIV/AIDS pandemic, both globally and domestically.

2. To improve domestic and international policies:
a. to apply universal protections of human rights to issues concerning HIV/AIDS,
b. to expand access to HIV/AIDS healthcare and treatment, and
c. to ensure access to accurate information about HIV/AIDS.

3. To amplify global awareness of HIV/AIDS and to facilitate broad-based change in attitudes to reduce stigma and change behavior.

4. To develop the leadership of organizations that fight HIV/AIDS; as well as to foster collaborations among those organizations and leaders.

This is the Foundation's long-standing program to provide project support. The Spring cycle is open to any organization that submits a concept letter (see Application Procedures) by December 15 for a project that matches one or more of the objectives listed above. The maximum grant award is $20,000.

Through this funding program the Foundation supports projects of newly developed non-profit organizations, of groups that have not yet been funded by the Lloyd Foundation, of small organizations, as well as novel demonstration projects and discreet small-budget projects of larger, more established organizations.

There is a two-pronged application process. Following a review of all submitted concept letters, the Foundation will request that a few (usually no more than twenty) organizations submit full proposals. Organizations are not eligible for more than three (3) consecutive Spring Cycle awards.

If you are unsure if your project matches the funding guidelines and objectives, please email info@johnmlloyd.org or call 310/ 622-1050.

The John M. Lloyd Foundation, a private family foundation, generally makes contributions to non-profit organizations that are described in section 501(c)(3) of the United States Internal Revenue code. The Foundation also makes grants to non-profit organizations based outside of the United States.

The Foundation prefers projects that have promise of making a significant impact and those which are new and innovative. The Foundation gives added preference to the development of programs that will significantly amplify the dollar amount of the grant.

In general, the Foundation does not make contributions:

* more than once per calendar year to any single organization
* more than three consecutive years to any single project
* to annual campaigns
* to operating budgets of established organizations
* to capital expenditures (physical plant, equipment, endowment)
* to indirect costs
* to individuals
* to locally-focused projects in the United States with the exception of locally-focused projects in California.
* to organizations that have annual budgets of $5 million or more
* for lobbying, as per federal restrictions on private foundations
* for health care or service provision
* for general support

The Foundation does make contributions to:

* locally-focused projects in California
* U.S.-based projects with a national or global scope
* International projects

The grant limit for the Spring Funding Cycle is $20,000.

The Foundation gives preference to organizations and projects that advocate for evidence-based policies, those that mobilize awareness and support for AIDS programs, and those that employ innovation to battle the HIV/AIDS pandemic.

The Foundation's specific funding objectives are:

1. To increase funding from public and private sectors to address the HIV/AIDS pandemic, both globally and domestically.
2. To improve domestic and international policies:
* to apply universal protections of human rights to issues concerning HIV/AIDS
* to expand access to HIV/AIDS healthcare and treatment, and
* to ensure access to accurate information about HIV/AIDS.
3. To amplify global awareness of HIV/AIDS and to facilitate broad-based change in attitudes to reduce stigma and change behavior.
4. To develop the leadership of organizations that fight HIV/AIDS; as well as to foster collaborations among those organizations and leaders.

The National Blood Foundation (NBF), established in 1983, has a history of supporting research and education that advances transfusion medicine and blood banking to benefit both patients and donors.

NBF is pleased to announce the availability of funding in 2009 for scientific research projects
related to transfusion medicine, to include aspects of immunology, hematology, tissue and
transplantation medicine, cellular therapies, emerging infectious disease, immunohematology,
donor health and recruitment and retention, and implementation of technological advances.
Priority is given to new investigators and innovative new projects with the potential to have a
practical impact on patients and donors in transfusion medicine. Grant terms may be for one or
two years, with a maximum total award per grant of $65,000 whether it is a one-year or two-year
grant. Awards will be announced by June 2009 and funds will be dispersed in July 2009.
Note that all applicants will be charged an application fee of $150 except for principal
investigators who are individual members of AABB. AABB institutional membership does not
qualify. To become an AABB member, please contact AABB Membership Services at
+1.301.215.6489 or membership@aabb.org.

When you have completed the five-part application, please email as five separate pdf file attachments in a single email to nbf@aabb.org by Monday, December 15, 2008. No applications will be accepted after that date. You will receive an email that your application has been received. If you do not receive an email, please contact us.

Notification of proposals selected for funding will be communicated in early June 2009 and funds will be disbursed in July 2009.

If you have any questions on this application process, please contact the NBF at nbf@aabb.org or at +1.301.215.6552.

National Blood Foundation
8101 Glenbrook Road
Bethesda, MD 20814-2749
Phone +1.301.215.6552
Fax +1.301.907.6895
Email: nbf@aabb.org

The DAN DAVID PRIZE annually awards 3 prizes of US$ 1 million each for achievements having an outstanding scientific, technological, cultural or social impact on our world. Each year fields are chosen within the three Time Dimensions - Past, Present and Future. The laureates for a given year are chosen from these fields.

The Dan David Prize is unique in its flexible definition of dynamically changing fields of human knowledge and in its process of fostering the next generation of scholars. The laureates annually donate 20 scholarships of $15,000 each to outstanding doctoral students throughout the world, in the chosen fields.

Nominations 2009 > General Information and Procedure

The fields within the three Time Dimensions for 2009:

PAST: Astrophysics - History of the Universe
PRESENT: Leadership
FUTURE: Global Public Health

The deadline for receipt of nominations is November 30th, 2008.

General Information:
Nominees for the Dan David Prize may be individuals or organizations. Specific and unique projects may be included if the head of the project is a nominee.
Winners for each Time Dimension are selected by the Dan David Prize Board, based on the recommendations of an international committee composed of world-renowned figures in the relevant field.
The committee may decide to select more than one winner for a specific prize if their achievements are considered to be of equal merit and impact on the relevant field.
The Dan David Prize is granted according to merit, without discrimination based on gender, race, religion, nationality, or political affiliation.
The work for which a nominee's recognition is sought may represent a singular achievement, a series of achievements, or a life's work. Nominees are considered only if their work and contributions represent exceptional and profound achievements in their fields.
Nominations may be submitted to the Dan David Prize only in accordance with the Dan David Prize guidelines and procedure, as detailed on Dan David Prize website and nomination form.
If a nomination is received based upon a nominee's contribution to a specific project, each member of that project should be listed separately, and his/her contribution to the project should be emphasized, as detailed in the Dan David Prize form.
If a nominee has been awarded the Dan David Prize, his/her/its right to that prize is not transferable to any other person/group/organization at any time.
An individual or organization can only receive the Dan David Prize once for the same achievement and/or contribution.
Self-nominations are not accepted.
Prize winners are required to participate in the award ceremony and the attendant events.
Based on complete discretion, the Dan David Prize may also call on foremost academic, research, and public institutions, prominent NGOs, high-ranking colleges and universities, outstanding public and academic figures, and former laureates of the Dan David Prize to nominate exceptional candidates, complying with the Dan David Prize requirements as specified in these regulations.
Where the major publications of a nominee are not in English, the relevant review committee may seek the assistance of an additional jury, as required. If no competent jury is found to the satisfaction of the relevant review committee, the committee may request translations of the publications into English, the cost of which will be borne by the nominee or nominator. The Dan David Prize will inform the nominator of the possible costs of translations and will request his permission to proceed with the review.
Guidelines:
Criteria for submission of nominations:
The individual or institution being nominated has made a unique, profound contribution to humanity, on a global scale, in one of the selected fields for the year in which the nomination is being made.
Required documents (in ENGLISH only, doc rtf or pdf format, Ariel or Times New Roman Font, minimum size 12) to be sent by email to ddpnomin@post.tau.ac.il:
Nomination form (completely filled-out).
A detailed description of the nominee's work (1-2 pages), stipulating reasons why the nominee merits the Dan David Prize. Please refer to the importance of the work, its impact, and its projected influence in the relevant field.
A full Curriculum Vitae of the nominee, or details prospectus in case the nominee is an organization.
A list of the nominee's publications of the last 15 years.
A list of the nominee's most relevant publications, stating full bibliographical details.
A photo of the nominee in electronic format, to be used by the Dan David Prize in case of need (300 dpi, copyright free, high-definition).
Confirmation of receipt will be sent by email.

Nominators will be notified of the Dan David Prize decision regarding the fate of their nomination.

The Gates Award for Global Health

The nomination deadline for the Gates Award is October 31, 2008.

In December, 2000, the Bill & Melinda Gates Foundation announced the establishment of the International Gates Award for Global Health. The Gates Award has been established to recognize an organization yearly that has made a major and lasting contribution to the field of global health.

The prize consists of a distinctive award sculpture and a prize amount of 1 million dollars.

The Gates Award for Global Health was established by the Bill & Melinda Gates Foundation to reward and exemplify organizations which have developed processes for improving health, especially in resource poor settings, with measurable results. The Gates Award for Global Health recognizes past achievements and the promise of continuing activity and improvement.

Any organization from any country in the world that has substantively improved the health and the lives of people in need may be nominated for the Gates Award for Global Health; the organization may be a charitable institution, a private company, or a public entity.

Nominations will be considered by an international jury consisting of health professionals from developing countries and the Global Health Council's Board of Directors. Nominations submitted will be reviewed by this jury and a winner will be selected. The jury member names will be publicized on the Global Health Council website once it is established.

The award will be presented in Washington, D.C., at a special Awards Ceremony during the Global Health Council's Annual International Conference. The winner's name is embargoed until the time of the ceremony.

Global Health Council

1111 19th Street, NW - Suite 1120
Washington, DC 20036
Tel (202) 833-5900
Fax (202) 833-0075

Request for Proposals for the Design
of a  Smallpox Eradication Monument
1.
Request for Proposals
The Board and the Secretariat of the Smallpox Eradication Commemoration - 2010 (SEC2010), through this Request for Proposals (RFP), invites designs for a work of public art to commemorate the eradication of smallpox. It will be located in a publicly-accessible area on the exterior grounds of the headquarters of the World Health Organization (WHO) in Geneva, Switzerland. The winning design will be awarded US$25,000 and each of four runners-up will receive $5,000.
2.
1Background
The year 2010 will mark the 30th anniversary of the World Health Assembly (WHA) formally confirming the report of the Global Commission for the Certification of Smallpox Eradication marking the elimination of this scourge of mankind.1 This unprecedented and lasting achievement of nations working together to benefit all the world’s people will be recognized with a “Monument” to inspire and educate the public of what can be achieved through global cooperation.
The Monument will be unveiled in May 2010 during the annual meeting of national ministers of health at the WHA at WHO headquarters. Private donations will fund the Monument and related commemoration activities, including a documentary film, an illustrated history book, and scientific symposia.
3.
2Monument Specifications
3.1.
7Type and material of structure
The proposed Monument may be of traditional or novel format, including one or a combination of the following, listed alphabetically, and not to the exclusion of others unlisted:
•
Architectural construct
•
Bas-relief
•
Mobile
•
Plaque
•
Sculpture
It should be constructed of metal, stone, concrete, glass, ceramic, and/or other durable materials.
1 The complete history of the global effort is documented in: Fenner F, Henderson DA, Arita I, Ježek Z, Ladnyi ID, eds. Smallpox and its Eradication. Geneva: World Health Organization, 1988, 1460 pages (ISBN-13: 9789241561106). The entire textbook is available online via URL hotlinks from this index file: http://whqlibdoc.who.int/smallpox/9241561106.pdf.
Smallpox Eradication Commemoration 2010 – RFP: Monument 12 August 2008 Page 2 of 7
3.2.
8Location
The Monument will be placed on the front entrance lawn of WHO Headquarters, in Geneva Switzerland (see http://earth.google.com coordinates: 46.233246° North latitude, 6.13437° East longitude). The exact location will be determined by WHO.
3.3.
9Size
The Monument “footprint” should be of comparable area (approximately 4 square meters) as the existing sculpture honoring onchocerciasis control2 on the lawn in front of the main entrance to WHO. Its maximum height should be 3 meters or less above grade. Any components higher than 1 meter above grade should be "light and airy" for harmony with its aesthetic and architectural surroundings.X2X Bulky, view-blocking designs may be disadvantaged in the selection process.
3.4.
10Maintenance-free
The Monument should be maintenance-free. No parts requiring electricity, water, or mechanical maintenance are allowed. Future external illumination of the Monument would be at the discretion of WHO.
3.5.
11Signage
Design proposals should include suggestions for how and where textual content will be integrated into or supplement the Monument on necessary plaques, engravings, or signs. Proposals optionally may suggest specific text (in English or with English translation), however the content of any signage will be determined by the SEC2010 Board and WHO.
4.
3Submission Requirements and Details
4.1.
12Eligibility
Anyone or any organization is invited to submit proposals for the Monument, including veterans of smallpox eradication efforts and employees of the WHO.
4.2.
13How to submit
Design proposals should be in English (or accompanied by full English translation), and submitted in accordance with the instructions on the APPLICATION FORM, the last page of this announcement, along with any supplementary information and materials.
4.3.
14Submission deadline
Submissions must be received on or before 31 October 2008 at 23:59 hours (11:59 p.m.) Greenwich Mean Time/Universal Time Coordinated (6:59 p.m. Eastern Standard Time USA; 00:59 next day Central European Time; 08:59 next day Japan Standard Time).

Emory Global Health Institute mailing address:

1599 Clifton Road, NE
6th Floor
Atlanta, GA 30322

Emory Global Health Institute phone number:

404-727-1433